一个统计模型来预测通过母体免疫接种对婴儿呼吸道突触性病毒疾病的保护
Bing Cai1, Yili Chen2, Yasmeen Agosti3
1Vaccine Research and Development, Pfizer Inc., Collegeville, PA 19426, USA.
Vaccines
|January 8, 2025
概括
针对呼吸道同胞病毒 (RSV) 的孕产妇免疫保护婴儿. 统计模型通过考虑母体抗体,转移,衰变和婴儿特异性风险,准确预测婴儿疫苗的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 儿科 儿科 儿科
背景情况:
- 呼吸道同胞性病毒 (RSV) 是导致婴儿呼吸道疾病的全球主要原因之一.
- 孕产妇免疫接种是一种保护婴儿的策略,利用胎盘抗体转移.
- 估计母体RSV疫苗的保护相关值是复杂的,因为免疫生物学和疾病因素.
研究的目的:
- 开发统计模型来预测母体免疫接种后婴儿疫苗疗效 (VE).
- 确定影响婴儿免受母体疫苗接种保护的关键因素.
主要方法:
- 开发了包括母体抗体标位,胎盘转移,抗体衰变率和RSV疾病发病率在内的预测统计模型.
- 在模型中包括了婴儿特定的因素,如气道直径和阻力.
主要成果:
- 模型预测与母亲RSV预注F疫苗试验中观察到的疫苗疗效结果非常相匹配.
- 婴儿下呼吸道疾病风险的整合对于准确的 VE 建模至关重要.
结论:
- 开发的模型成功预测了母体RSV疫苗的疫苗疗效.
- 这些模型为预测其他疫苗的临床试验结果提供了有价值的工具,其中母体抗体具有保护作用.
更多相关视频
13:00Intranasal Immunization and Milk Collection in Studies of Maternal Immunization in New Zealand White Rabbits Oryctolagus cuniculus
Published on: July 31, 2021
3.5K
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
7.9K
相关概念视频
Vaccinations
44.0K
Overview
44.0K
Development of Immunocompetence
283
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
283
